Findings from a few small intervention studies targeting depressed individuals without diabetes at baseline have shown that depression treatment improves a marker of prediabetes known as insulin sensitivity, particularly among patients whose achieved depression remission [4–6]. This evidence concerns the gene INS and major depressive disorder.